Research by Wistar Institute scientists shows how targeting a cleft in the retinoblastoma protein can kill tumor-protecting macrophages in ovarian cancer. The discovery provides a novel therapeutic target that could potentially make ovarian and other cancers more sensitive to immunotherapies.
The Northwell Cancer Institute has unveiled its Center for Women’s Cancer at the R.J. Zuckerberg Cancer Center.
